Eisai Clinical Trials
Study Overview
E2027
irsenontrine
NCT03467152, 2017-003728-64, JapicCTI-183932
May 2018 - Apr 2020
Dementia With Lewy Bodies
1. Change From Baseline in the Montreal Cognitive Assessment (MoCA) Total Score at Week 12 of Treatment [Time Frame: Baseline and Week 12]
2. Number of Participants Based on Clinician's Interview Based Impression of Change Plus Caregiver Input (CIBIC-Plus) Scale at Week 12 of Treatment [Time Frame: Week 12]
-
Males and females 50 Years to 85 Years (Adult, Older Adult)
-
Completed -
Phase 2
France, Germany, Italy, Japan, Spain, United Kingdom, United States See moreData Sharing
ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.
CSDR Sharing is not available for this study.
CSDR Availability Clinical Trial Data Redacted documents may be available upon request for this study.
Document type Availability Protocol SAP Sample CRF Full CSR